Mira Pharmaceuticals Inc. (K6S)
FSX
Closed
Aug 25, 2026
Day's Range
0.641552 wk Range
0.5400Overview - K6S - Mira Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
14.48M
P/E (Trailing)
‪-0.47‬
PEG Ratio
‪0.0065‬
Price / Book
‪3.58‬
EV / EBITDA
‪-1.38‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-129.54%‬
Return on Equity
‪-217.12%‬
Ownership
Shares Outstanding
42.02M
Float
35.02M
Held by Insiders
‪30.58%‬
Held by Institutions
‪5.42%‬
Price stats
Beta
‪1.55‬
50-Day Avg
‪0.7380‬
200-Day Avg
‪0.9418‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - K6S - Mira Pharmaceuticals Inc.
Peers - K6S - Mira Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- K6SFSXMira Pharmaceuticals Inc.25.02MMarket Cap-101.51%52-week change-0.44P/E (Trailing)‪0.00%‬Profit Margin
- LLYFSXEli Lilly and Company967.12BMarket Cap+44.42%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR888.80BMarket Cap+39.18%52-week change38.26P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson566.92BMarket Cap+35.24%52-week change31.88P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR520.56BMarket Cap+33.96%52-week change29.17P/E (Trailing)‪21.48%‬Profit Margin
- 4ABFSXAbbVie Inc.402.01BMarket Cap+22.14%52-week change75.13P/E (Trailing)‪9.80%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR364.00BMarket Cap+19.44%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
Profile Summary - K6S - Mira Pharmaceuticals Inc.
About
Mira Pharmaceuticals Inc. operates in the biotechnology industry, focusing on the research and development of novel therapeutics. The company is dedicated to advancing pharmaceuticals that address unmet medical needs, primarily targeting neurological and neuropsychiatric disorders. Through innovative drug development…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
